2019

Ichthyosis Vulgaris
Sponsor: Crown
A Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of Urea
Cream, 40% applied twice-daily for 6 weeks in subjects with Ichthyosis Vulgaris
Phase:
Start Date: 1/2019
End Date: Ongoing

Atopic Dermatitis
Sponsor: AOBiome
An open-label, multicenter, Phase Ib study of B244 delivered as a topical spray to assess safety in pediatric subjects ages 2 to 17 years with atopic dermatitis
2-17 years
Phase: 1b
Start Date: 1/2019
End Date: Ongong

Plaque Psoriasis
Sponsor: Lilly
A 24-Week Multicenter, Randomized, Double-Blind, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Guselkumab in Patients with Moderate-to-Severe Plaque Psoriasis
Phase: 4
Start Date: 1/2019
End Date: Ongoing

Palmar Hyperhidrosis
Sponsor: Dermira
A Phase 2, Randomized, Double-Blind, Vehicle-Controlled Efficacy and Safety Study of Glycopyrronium
Cloth, 2.4% in Patients with Palmar Hyperhidrosis
Phase: 2
Start Date: 2/2019
End Date: Ongoing

Atopic Dermatitis
Sponsor: Leo Pharma
An open-label, single-arm, multi-centre, long-term extension trial to evaluate the safety and efficacy of tralokinumab in subjects with atopic dermatitis who participated in previous tralokinumab clinical trials
Phase: 3
Start Date: 3/2019
End Date: Ongoing

Plaque Psoriasis
Sponsor: Therapeutics
A Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Proof of Concept Comparison Study of the Safety and Efficacy of DUR-928 Topical Solution with Occlusion in Subjects with Mild to Moderate Plaque
Psoriasis
Phase:
Start Date: 3/2019
End Date: Ongoing